Results 101 to 110 of about 7,754 (200)

Estradiol-associated extracellular signaling in the human breast <i>in vivo</i> identifies mast cells as tumor-supportive stromal mediators. [PDF]

Oncoimmunology
Abrahamsson A, Wang X, Zhong W, Dabrosin C.   +3 more
europepmc   +1 more source

Desloratadine [PDF]

, 2020
openaire   +1 more source

Second-generation H1 antihistamines for the treatment of chronic urticaria: a network meta-analysis. [PDF]

Front Med (Lausanne)
Li Z, Zhang J, Zheng Y, Zhang M, Du W, Zhang Y, Gao X, Zhu Q, Qi J, Zhao Z, Liu L.   +10 more
europepmc   +1 more source

Antidiabetic Properties of Histamine H1 Receptor Antagonists: A Systematic Review. [PDF]

Antioxidants (Basel)
Radzikowski M, Maciejczyk M.
europepmc   +1 more source

Desloratadine attenuates renal ischemia-reperfusion injury through activation of the Nrf2-GCL-GSH antioxidant pathway. [PDF]

Curr Res Pharmacol Drug Discov
Gholampour F, Maghsoodi A, Malekmohammad K.   +2 more
europepmc   +1 more source

Plant-Derived Diamine Oxidase Modulation of Histamine-Induced Ca²⁺ Release in Intestinal Caco-2 Cells: A Cellular System to Evaluate Its Histaminase Efficacy. [PDF]

Cells
Neree AT, Jumarie C, Marcocci L, Pietrangeli P, Mateescu MA.   +4 more
europepmc   +1 more source

Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist - 2nd communication: Lack of central nervous system and cardiovascular effects

, 2000
Desloratadine (descarboethoxyloratadine, CAS 100643-71-8) is a selective histamine H1 antagonist that exhibits qualitatively similar pharmacodynamic activity to its parent, loratadine (CAS 79794-75-5), but is 2.5-4 times more potent orally. In studies of
Hey, JA, Barnett, A, Kreutner, W, Chiu, P   +3 more
core  

LA DESLORATADINE, EVALUATION PHARMACO-ECONOMIQUE D'UN DEVELOPPEMENT EN MEDECINE VETERINAIRE

, 2003
La desloratadine est un nouvel antihistaminique H1 de seconde génération développé par le laboratoire Schering-Plough dans le traitement des allergies dans l'espèce humaine.
JOSEPH-ENRIQUEZ, Brigitte, MIGNON, M.O
core  

HPCAL1 promotes colorectal cancer progression via TCF7/p65-mediated Wnt ligand upregulation and Wnt/β-catenin pathway activation. [PDF]

Oncogenesis
Cheng L, Zhang H, Guo L, Zhang Q, Zhang Y, Xie Q, Zhou S, Wen D, Chen W, Wang Z, Zhang J, Thorne RF, Zhu Z.   +12 more
europepmc   +1 more source

Administration of Desloratadine for Postorgasmic Illness Syndrome in a Japanese Teenager. [PDF]

IJU Case Rep
Ito K, Kobayashi K, Hashimoto K, Yorozuya W, Okabe K, Nofuji S, Sakai Y, Kyoda Y, Tanaka T, Masumori N.   +9 more
europepmc   +1 more source